tiprankstipranks
Bio-Gene Technology Ltd. (AU:BGT)
ASX:BGT
Australian Market

Bio-Gene Technology Ltd. (BGT) Financial Statements

Compare
6 Followers

Bio-Gene Technology Ltd. Financial Overview

Bio-Gene Technology Ltd.'s market cap is currently AU$6.64M. The company's EPS TTM is AU$-0.014; its P/E ratio is ―; Bio-Gene Technology Ltd. is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 18.32KAU$ 595.08KAU$ 879.78KAU$ 573.12KAU$ 907.58K
Gross ProfitAU$ -301.45KAU$ 281.80KAU$ 612.64KAU$ 399.92KAU$ 640.45K
Operating IncomeAU$ -3.06MAU$ -3.18MAU$ -2.97MAU$ -2.47MAU$ -2.16M
EBITDAAU$ -2.97MAU$ -3.14MAU$ -2.92MAU$ -2.39MAU$ -2.05M
Net IncomeAU$ -2.41MAU$ -3.10MAU$ -2.80MAU$ -2.36MAU$ -1.87M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 2.21MAU$ 2.99MAU$ 6.34MAU$ 3.93MAU$ 5.52M
Total AssetsAU$ 3.16MAU$ 3.84MAU$ 7.30MAU$ 5.00MAU$ 6.57M
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 11.66K
Net DebtAU$ -2.21MAU$ -2.99MAU$ -6.34MAU$ -3.93MAU$ -5.51M
Total LiabilitiesAU$ 368.45KAU$ 613.88KAU$ 1.03MAU$ 754.57KAU$ 567.29K
Stockholders' EquityAU$ 2.79MAU$ 3.22MAU$ 6.27MAU$ 4.25MAU$ 6.00M
Cash Flow
Free Cash FlowAU$ -2.76MAU$ -3.28MAU$ 36.67KAU$ -1.83MAU$ -1.64M
Operating Cash FlowAU$ -2.75MAU$ -3.28MAU$ 43.52KAU$ -1.83MAU$ -1.64M
Investing Cash FlowAU$ -5.70KAU$ 0.00AU$ -6.84KAU$ -3.03KAU$ 0.00
Financing Cash FlowAU$ 1.98MAU$ -75.00KAU$ 4.41MAU$ 239.88KAU$ 2.67M
Currency in AUD

Bio-Gene Technology Ltd. Earnings and Revenue History

Bio-Gene Technology Ltd. Debt to Assets

Bio-Gene Technology Ltd. Cash Flow

Bio-Gene Technology Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis